RKLB

-0.070.310.691.07

Investus Reports

๐Ÿ” AnalysisRKLB2026.11.11 09:00

Rocket Lab โ€” 3 Houses Trim Targets After Q3 | Neutron Timing Is the Key Variable

Three houses trimmed Rocket Lab price targets after Q3 earnings: Cantor Fitzgerald ($122โ†’$111, Overweight), Barclays ($85โ†’$82, Overweight), Piper Sandler ($83โ†’$58, Neutral). All three cite Neutron rocket timing as the core variable. Two of three maintain Overweight โ€” the long-term case is intact.

RKLB Analysts

Member #22RKLB2d

RKLB targets trimmed but 2 of 3 kept Overweight. 'Record bookings, higher Neutron pricing' from Barclays confirms Electron health and Neutron pricing power simultaneously. Neutron first flight de-risking is the re-rating trigger.

โ™ฅ 25 0

RKLB Discussion

View all
A
Memberโœ“ Member2d

RKLB post-Q3: Cantor ($122โ†’$111), Barclays ($85โ†’$82), Piper ($83โ†’$58) all trimmed. But Cantor and Barclays kept Overweight โ€” long-term case intact. 'Record bookings, higher Neutron pricing' per Barclays. It all comes down to Neutron first flight timing

โ™ฅ 27 0

Related News

View Past Sessions